Oncogenic hyperplasia is the first and inevitable stage of formation of a (solid) tumor. This stage is also the core of many other proliferative diseases. The present work proposes the first minimal model that combines homeorhesis with oncogenic hyperplasia where the latter is regarded as a genotoxically activated homeorhetic dysfunction. This dysfunction is specified as the transitions of the fluid of cells from a fluid, homeorhetic state to a solid, hyperplastic-tumor state, and back. The key part of the model is a nonlinear reaction-diffusion equation (RDE) where the biochemical-reaction rate is generalized to the one in the wellknown Schlögl physical theory of the non-equilibrium phase transitions. A rigorous analysis of the stability and qualitative aspects of the model, where possible, are presented in detail. This is related to the spatially homogeneous case, i.e. when the above RDE is reduced to a nonlinear ordinary differential equation. The mentioned genotoxic activation is treated as a prevention of the quiescent G0-stage of the cell cycle implemented with the threshold mechanism that employs the critical concentration of the cellular fluid and the nonquiescentcell-duplication time. The continuous tumor morphogeny is described as a time-space-dependent cellular-fluid concentration. There are no sharp boundaries (i.e. no concentration jumps exist) between the domains of the homeorhesis-and tumor-cell populations. No presumption on the shape of a tumor is used. To estimate a tumor in specific quantities, the model provides the time-dependent tumor locus, volume, and boundary that also points out the tumor shape and size. The above features are indispensable in the quantitative development of antiproliferative drugs or therapies and strategies to prevent oncogenic hyperplasia in cancer and other proliferative diseases. The work proposes an analytical-numerical method for solving the aforementioned RDE. A few topics for future research are suggested.
INTRODUCTION
In multicellular organisms, one of the fundamental tasks resolved by homeosta-sis (Cannon, 1929) or, more generally, homeorhesis (Waddington, 1957) is the maintenance of the numbers of all types cells at physiologically acceptable levels.
The biological cell is the least structural aggregate of living matter capable of functioning as an independent unit. A living particle (e.g., a cell, or an animal, or a human being, a social group or a part of ecological system) is, by definition, always changing in time, moving along some defined time path, from an initial stage (such as the fertilized egg) through various larval stages to adulthood, and finally to senescence. The regulation that occurs in such a system is a regulation, not necessarily back to a static stable equilibrium, as in homeostasis, but to a more general stable mode which lies on some future stretch of the time path. The appropriate notion describing this process is homeorhesis. It was introduced by Waddington (1957, p. 32 ) (see also Waddington, 1968, p. 526) . Loosely speaking, homeorhesis is a self-regulating process by which living systems tend to maintain the stability of their internal environment while adjusting dynamical conditions that are optimal for survival. If homeorhesis is successful, life continues; if unsuccessful, disaster or death occurs. The stability attained is actually a dynamic equilibrium, in which continuous changes take place. Any system in dynamic equilibrium tends to reach a steady state, a dynamic long-lasting balance. One of the key mechanisms here is clock-like, nearly periodic self-sustained oscillations (e.g., Yates and Iberall, 1982 , Point 16-18 on p. 431; see also Chen and Aihara, 2002 , for examples of specific models). In other words, homeorhesis is the time-dependent extension of homeostasis. Homeostasis is generally a spatially inhomogeneous, -dependent state. However, the homeorhetic equilibrium is dynamic rather than static. In these terms, homeostasis is the time-independent homeorhesis.
The cell-number maintenance is commonly considered in connection with populations of cells, or cellular fluids, at habitual, fluid-phase concentrations. Extremeconcentration states of cellular fluids, such as amorphous solid phases, can also be the case in organisms. One example is tumors (e.g., Franks and Teich, Eds., 1997) . The connection of homeostasis, or more generally, homeorhesis (see Section 3) to the transitions of cellular fluids from fluid to solid states (or back) remains unclear.
Development of a tumor, or oncogeny, comprises a few well known stages such as hyperplasia, dysplasia, in situ growth, angiogenesis and invasion (e.g., see the figure "Five stages of tumor" in the article "Tumour", Encyclopaedia Britannica Online, 2003, for a concise summary). It is well known that tumors at the latter, malignant stages (angiogenesis or invasion) are especially difficult to eliminate or suppress. "Cancer remains a disease of high unmet clinical need where life expectancy can often be short. In 1999, there were over 12 million new cases of cancer diagnosed and 7 million deaths" (Hughes, 2001) . Unluckily, "killing the last cancer cell without killing the host is an objective that has not yet been reached" (Israel, 1996, p. 379) . Moreover, the disease can be made even worse by iatrogenic (Gove, 1993 , the middle column on p. 1119), i.e. physician-induced, effects resulting from the above all-cancer-cell-killing strategy pursued without a proper system analysis.
In order to help to develop better clinical strategies the present work focuses on oncogenic hyperplasia, the first and therefore inevitable stage in development of any (solid) tumor. Oncogenic hyperplasia is also implicated in many other proliferative diseases, for instance: vascular proliferative diseases (atherosclerosis and coronary restenosis); gastrointestinal polyps (especially in the rectum and colon; e.g., pedunculated tumors); endocrine proliferative diseases (hyperparathyroidism, hypoglycemia in infants, and congenital adrenal hyperplasia); proliferative dermatoses (infantile eczema and lichenification); megakaryocytic or platelet hyperplasia; hyperplasia of cardiac muscle; hyperplastic lesions of the larynx; ductal, prostatic, intimal, endometrial, and lymphoid hyperplasias. Oncogenic hyperplasia is a process that is gradual in both space and time, in which quantitative changes in the cell-population characteristics result in qualitative differences. It is not possible to investigate this process with common tools. Indeed, biomedical experiments or animal models are inherently fragmentary and quantitatively unspecific. There is no equipment capable of providing cell population data that are continuous in both space and time. Hyperplastic lesions (if not pathological) are deeply presymptomatic, subclinical, and difficult to detect. The only way to overcome the above difficulties is to apply predictive mathematical models and related software. These are the tools that would also enable an improved understanding of the fundamental stage of oncogeny and would thereby contribute to its prevention. The latter is in principle the most efficient approach: "Prevention is always preferable to cure" (V. R. Potter, 1945) . The enormous importance of oncogeny and cancer prevention has already been recognized even at the level of establishing dedicated institutions (e.g., see "Institute for Cancer Prevention. Prevention is the Best Cure" at http: //www.ifcp.us and "American Health Foundation: Research" at http://www.ahf.org /research/). However, such prevention has not yet become an everyday practice. More research and development remain to be done in the field. This requires the combined efforts across a wide range of disciplines including biology. The present work is a step in this direction.
Oncogenic hyperplasia is regarded as a process caused by either genotoxicity of cells (e.g., Trosko et al., 1990, p. 241) , i.e. their undesirable genetic mutations (Bishop, 1991; DePinho, 2000; Campbell and Farrell, 2003, Sect. 11.8; Lichtenstein and Potapova, 2003) , or as a homeorhetic (in particular, homeostatic) dysfunction (e.g., Potter, 1945; Iversen, 1965) . Importantly, these factors are not mutually exclusive. Indeed, hyperplasia is affected by nonmutational, epigenetic processes which may "masquerade as mutations" (e.g., see Kerbel et al., 1984, p. 89 ; see also Franks and Teich, Eds., 1997, Sect. 2.7.2, Chs. 9 and 10) . Additionally, neither of the above factors on its own can completely explain hyperplasia (e.g., Trosko et al., 1990, Sect. "Introduction") . This also means that "cancer research should no longer try to find the cause of cancer within one cell, but start to study the information and the transfer of information between cells" (Iversen, 1965, p. 104) .
In line with the above vision, the present work develops a model for the cellnumber maintenance by homeorhesis in conjunction with the genotoxically activated dysfunction shown by oncogenic hyperplasia. The model derivation follows the ideas suggested more than 65 years ago by Rashevsky (1938, pp. 134-135) : "In biology, like in other natural sciences, we find that in spite of the tremendous variety and complexity of the phenomena observed, certain uniformities become apparent upon closer examination. The existence of such uniformities, of such a unity in diversity is one of the prerequisites for the possibility of existence of any exact sci-ence". The "unity in diversity" can be regarded as one of the core principles of systems biology, a very young but rapidly developing science (e.g., Pennisi, 2003; Kitano, 2002 ). The present work attempts to reach an "exact science" by means of a fairly specific approach to Rashevsky's "unity in diversity". The derivation of the model deliberately involves the mathematically simplest assumptions, dependences and steps. It takes into account a limited number of necessary effects and parameters. In so doing, the two factors leading to hyperplasia, homeorhetic dysfunction and cell genotoxicity, are combined in unambiguous and clear terms. Some of the results in this work were previously reported by and .
The work focuses on the concentration of cells rather than their number for the following reason. The homeorhetic maintenance of the cell number deals with the number of the cells at time point in bounded or unbounded domain , . If one attempts to describe function , the resulting models will generally be enormously cumbersome since this function is not a function of points in but a function of sets of these points. The problem is, however, easily eliminated by introduction of the notion of concentration (or volumetric density of the number) of the cells. Indeed, number is expressed as follows
where is the concentration of the cells at moment and at point . Representation (1.1) completely describes function with function , i.e. the function of sets is reduced to a function of the points in these sets. This advantage allows one to study the homeostatic maintenance of number by means of modelling concentration . The latter is a much less complex task. Subsequently, the present work focuses on the maintenance of the concentration.
The structure of the work can be well characterized with the following main topics of the sections and appendixes:
• volume scaling and the scaled concentration (Section 2); • the ideal-homeorhesis model (Section 3); • the scaled concentration in regeneration and inflammation at ideal homeorhesis (Section 4); • oncogenic hyperplasia as a homeorhetic dysfunction (Section 5);
• the hyperplastic-tumor/nonquiescent-cell asymptote (Section 6); • the core phase-transition-endowed model for the hyperplasia-extended homeorhesis (Section 7); • the summary for the core-model analytical analysis in the particular case of homeostasis (Section 8); • the birth, life, and death of oncogenic hyperplasia (Section 9); • the diffusion generalization of the core model to morphogeny: the PhasTraM model (Section 10); • a discussion, concluding remarks and directions for future research (Section 11);
• the fundamental role of a point hyperplastic tumor in oncogeny and its definition in physical terms (Appendix A);
• the relation of the core and minimal models to Schlögl's theory of non-equilibrium phase transitions of the first and second orders (Appendix B); a good introduction to this theory can be found in Haken (1977, Sect. 9 .3); • the time-slice method for solving the Cauchy problem for the PhasTraM reaction-diffusion equation (Appendix C).
The work considers a cell population as a cellular fluid suspended in the extracellular fluid (a water-like molecular/ionic fluid). A particular case of the extracellular fluid is the interstitial one, the fluid component of the extracellular matrix.
VOLUME SCALING AND SCALED CONCENTRATION
Since the volume of a cell is generally not negligible, the work applies the volume-scaling method (VSM) (see Appendix A.2; see also Mamontov and Willander, 2003a, Sects. 2-3; Mamontov, 2005, Sects. 2-6) . According to VSM, the effect of the fluid-particle volume is accounted for in terms of the scaled concentration, , of the cellular fluid and the fraction, , of the physical-space volume in which the cells are free to move. These quantities are related as follows (cf., Remark A.3) (2.1) (Line 1 of Table 2 for ). The present work deals with fluids which include two components (see the end of Section 1), cellular and extracellular, and, thus (see the text above (A.4)). Let and be the fraction of the volume occupied by the bodies of the extracellular-fluid particles (cf., Line 2 of Table 1 ) and the volume of a cell (cf., Line 3 of Table 1 ), respectively. Then (see also Line 1 of Table 1 Table 1 ). For each of the above stages, the time-space Cauchy problem, i.e. the one in the entire physical space , can be adequate. To allow for an in-situ-growing tumor, one has to consider an oncogeny model on a semi-bounded or bounded domain rather than on . In so doing, the corresponding boundary conditions have to be involved. The angiogenesis stage of oncogeny makes it necessary to take into account the -dependence of parameter (see (2.5), (2.6), Line 1 of Table 1 and the text below (A.5)) since becomes affected by the volume fraction occupied by the blood-vessel system in a tumor. In the case of the invasion stage of oncogeny, the model is to be applied to different space regions connected with blood vessels. This corresponds to the most general settings of the model.
The model for , which includes the hyperplasia-homeorhesis competition, is derived in Section 7.
THE IDEAL-HOMEORHESIS MODEL
The notion of homeorhesis is discussed in the second paragraph of Section 1. Specific examples of homeorhetic behavior can be found in Haus and Smolensky (1999) . The meaning of homeorhesis points out the following. Let In view of (2.7), the value of scaled concentration corresponding to is (see (see Line 5 of Table 2) .
(3.3) Property (3.2) means that the quantity does not explicitly depend on , depends on , is of the same smoothness as , and is uniformly bounded for all where it is defined. These features are used, for instance, in (3.4), (6.1), (7.1), (7.14), (7.18), (7.19), and (7.29) The position vector is a parameter in ODE (3.4). The initial condition (3.7) means that the cellular fluid achieves the concentration value by time in the course of the previous development, i.e. for . Thus, the function is not predicted by the present model. It is merely used as one of the input parameters (cf., Line 5 of Table 1 ). The output characteristics of the model are, according to the text in Section 1 on (1.1), the cellular-fluid concentration dependent on and with the values corresponding to (2.3). Equation (3.4) is, under the FFT condition in (2.9) (see also (3.3)), representable as . Subsequently, the positive parameter can be interpreted as the inverse of the lifetime of the ideal-homeorhesis cells in the ideal state (see Line 6 of Table 1) as follows (see Line 7 of Table 2) (3.8)
The term "ideal" is used for the reasons explained the text below (5.1).
SCALED CONCENTRATION AT REGENERATION AND INFLAMMATION IN THE IDEAL-HOMEOSTASIS CASE
This section considers certain distinguishing behaviors of the scaled concentration at the cell regeneration and inflammation in the ideal-homeostasis case, i.e. when the ideal homeorhesis (cf., Section 3) is independent of , . For simplicity, it is assumed that is also independent of .
The cellular fluid when can be exemplified with a regeneration of the cells resulting from an injury. In this case, solutions of ODE (3.4) are monotonically increasing, tend to asymptote , and are strictly concave (e.g., see Hazewinkel, Ed., 1988b, pp. 294 and 415 for the definition of concave and strictly concave functions). The concavity points out that tends to rather fast. The opposite case, i.e. when exceeds the homeostatic value , i.e. , corresponds to an abnormal accumulation of the cells. This accumulation usually results from an inflammation. The latter is characterized by such hallmarks as capillary dilatation and the infiltration of the cellular-fluid environment by macrophages, lymphocytes, and plasma cells (i.e. mature antibody-producing B lymphocytes). Inflammatory cells release a variety of potentially harmful and genotoxic substances (such as oxygen, interleukines, interferons, colony-stimulating factors, tumor necrosis factors, and growth factors) which are chemical signals (or messengers; see Bullough, 1962, p. 332) in the form of the molecules or macromolecules (usually, polypeptides) known as cytokines. They affect cells by promoting their mitosis (i.e. division) or suppressing their apoptosis (i.e. programmed death), thereby increasing concentration . Thus, the cytokines mentioned above form a positive feedback and, for this reason, can briefly be termed the positive cytokines. The cells in the fluid at can be regarded as the inflamed cells. In addition to the positive cytokines, free radical scavengers as well as differentiation and inhibitory factors are also generated. The influence of these cytokines upon cells is opposite to that of positive cytokines. Namely, they affect cells by suppressing their mitosis (e.g., in a similar way to the mitosis chalones introduced by Bullough, 1962, p. 332) or promoting their apoptosis, thereby decreasing concentration . The cytokines of this group form a negative feedback and, thus, can briefly be termed the negative cytokines. Examples of the latter are reported, for instance, by Lavagna (et al., 1999) and Freeman (2000, pp. 316-317) .
The net effect of the above phenomena in vivo depends on the balance of the positive and negative feedbacks. At inflammation , solutions of ODE (3.4) are monotonically decreasing, tend to asymptote (similar to the behavior in the above regeneration case of ), and strictly convex (e.g., see Hazewinkel, Ed., 1988b, p. 415 for the definition of convex and strictly convex functions). Thus, the solutions tend to rather fast. Here the negative feedback dominates over the positive feedback. This picture corresponds to an acute inflammation.
A chronic inflammation is long-lasting. Subsequently, one can expect that reducing approaches very slowly and hence is strictly concave during a noticeable time. However, after crosses an inflexion value, it becomes strictly convex tending to much faster and thereby manifesting an acute inflammation. The reduction of means that the negative feedback dominates over the positive one but this dominance is less pronounced in the concavity interval than in the convexity one. The problem of the ideal-homeorhesis ODE (3.4) where is -independent is that it alone can not describe the concavity manifesting a chronic inflammation.
ONCOGENIC HYPERPLASIA AS A HOMEORHETIC DYSFUNCTION
The aforementioned drawback of equation (3.4) is not the only one. Indeed, ODE (3.4) is the simplest version of the so-called evolution equations with convergence (e.g., Demidovič, 1967, Ch. IV, §16 ). An equation of this type is by definition the equation that has an unique, generally -dependent solution which is uniformly bounded for all and any other solution of the equation converges to this solution. The latter is called the steady-state solution. In other words, the steady-state solution is the global attractor. Models of this type are highly re-levant to homeorhesis (cf., Section 3). However, the evolution with the globally attracting steady state does not take into account the cases when at least one solution grows unlimitedly.
In particular, ODE (3.4) cannot allow for unlimited growth
This equation is equivalent to the formation of a point hyperplastic tumor because of (2.8), (2.2), and Definition A.2. Along with this, the relation is also equivalent to a nonstationary (and hence non-equilibrium) phase transition of the cellular fluid to a solid state because of Remark A.2. The phase-transition paradigm endows the oncogenic hyperplasia with a sharp physical reading. This interpretation underlies the present work that deals with hyperplastic tumors only (cf., Remark 2.2). Hyperplasia is related to homeorhesis since it can be regarded as a homeostatic and hence homeorhetic dysfunction. Indeed, the section "Carcinogenesis, a multistage process leading to homeostatic dysfunction" of Trosko (et al., 1990) includes in depth discussion on this topic (see also the corresponding references therein). In the present treatment, the above dysfunction can be described with equation (5.1) if it is combined with the ideal-homeorhesis model (3.4). The latter, in the light of (5.1), describes the ideal state of the cellular fluid. This also explains the term "ideal" in the text on (3.8). The subsequent question is how to endow ODE (3.4) with option (5.1).
THE HYPERPLASTIC-TUMOR/NONQUIESCENT-CELL ASYMPTOTE
The simplest model similar to (3.4) which takes into account (5.1) is obviously , , (6.1) where does not explicitly depend on . Since is positive, ODE (6.1) (or, more generally, (7.18) below) is, in the hyperplastic-tumor limit case (5.1), the hyperplastic-tumor asymptote. It is defined for all and is also the infinite-(cf., (5.1)) asymptote that corresponds to the nonquiescent (NQ) cells, i.e. the ones which do not enter the quiescent nondividing stage. Subsequently, we term ODE (6.1) (and its generalization (7.18)) the hyperplastic-tumor/nonquiescent-cell (HT/NQ) asymptote. One can estimate parameter in (6.1) as follows (6.2) where term (see Line 8 of Table 2 ) is explained in the remark below.
REMARK 6.1. Equation (6.1) is, under the FFT condition in (2.9) (see also (3.3)), representable as . Subsequently, in (6.2) can be interpreted as the HT/NQ-cell duplication time (i.e. the time from the birth of a cell to the moment of its division into two new cells (see Line 7 of Table 1 )) under the FFT condition.
The cell-duplication time depends on the type of the cells. It is usually between a few tens of minutes and a few tens of hours. For embryonic cells of vinegar flies (also called fruit flies), is about minutes. It is well known (e.g., Campbell and Farrell, 2003, p. 272 ) that the cell duplication of the eukaryotic cells consists of four stages, the , , , and stages. The and "follow canonical steps that vary little from cell to cell" (Massagué, 2004, p. 298) . The durations of these stages are nonzero,
. In contrast to this, the and stages "are largely dependent on cell type and context" (Massagué, 2004, p. 298) . The durations of these stages can be zero (Massagué, 2004, p. 299 and Fig. 1), . Thus, the HT/NQ-cell duplication time is expressed as follows .
In general, changes in (e.g., down to the values not less than ) depend on various genotoxic biological signals (e.g., Massagué, 2004; Kitazono et al., 1999) .
Quantitative approaches (e.g., Ubezio, 2004) can help to develop models for .
THE CORE PHASE-TRANSITION-ENDOWED MODEL FOR THE HYPERPLASIA-EXTENDED HOMEORHESIS
Equation (6.1) radically differs from equation (3.4) because of the opposite signs on the right-hand sides. The simplest way to endow (3.4) with the capabilities of (6.1) is an interpolation between the negative constant and the positive constant . The simplest, linear interpolation results in the following combination of (3.4) and (6.1) or , , (7.1) where . (7.2) Equation (7.1) is the very one that couples ideal homeostasis (3.4) with the hyperplasia option (6.1) (or (5.1)) that presents the homeostatic dysfunction. The righthand side of equation (7.1) is the biochemical-reaction term for the scaled concentration . Relation (7.2) allows one to interpret as some probability. Due to the nature of the form of the right-hand side of (7.1), is the probability that the cellular-fluid is involved only in the homeostatic convergence of to finite whereas is the probability that the cellular-fluid is involved only in the unlimited growth of to infinity, i.e. in hyperplasia (5.1) or, equivalently, in the aforementioned phase transition. Since the probabilities and are complementary, ODE (7.1) allows for that the homeostatic convergence and hyperplasia constitute an alternative.
It is convenient to parametrize probabilities and with the probability ratio where, in view of (7.2), .
(7.5)
The meaning of and (see the text between (7.2) and (7.3)) implies that , , .
(7.6) Indeed, ratio (7.3) is expected to be proportional to the growing quantity, i.e. (see (5.1)) . This leads to the second relation in (7.6). At zero , there is no hyperplasia. This is expressed with the first relation in (7.6). Finally, in case of (5.1), the hyperplasia probability strongly dominates over the homeorhetic-convergence probability . This is specifically formulated with the third relation in (7.6).
The simplest -dependence of which agrees with both (7.5) and (7.6) is
where the value of is called the median value (cf., Line 9 of Table 2 ) because of issues explained in Remark 7.1 below. The form (7.7) is assumed in what follows. In spite of the simplicity of expression (7.7), this expression endows the present approach with nonstationary-phase-transition capabilities and (see Remark B.2 in Appendix B) turns out to be highly relevant.
In case of (7.7), the probabilities (7.4) become , .
(7.8) REMARK 7.1. If one regards scaled concentration of the cellular fluid as the value of a stationary stochastic process with the stationary random variable then the following interpretation is applicable. Let the stationary random variable for the process be . Its values are described with where is the elementary event and is the space of elementary events. It follows from (7.8) that probability density of random variable is , .
(7.9) Interestingly, this density is the simplest rational member (Lachenbruch and Brogan, 1971 , (1)) of the Lachenbruch-Brogan probability-density family (Lachenbruch and Brogan, 1971, (3) ). The median of the probability distribution corresponding to density (7.9) is . This explains the above term "median value" for (see the text below (7.7)). No moments of probability density (7.9) exist (Lachenbruch and Brogan, 1971 ). This feature is relevant in the case under consideration, i.e. when the density describes the stationary (scaled) concentration of the cellular fluid. Indeed, would the expectation (i.e. the first moment) exist, then it would be difficult to interpret this concentration value since both the homeorhetic convergence to and oncogenic hyperplasia, i.e. growth to infinity, are in principle equally represented processes. The latter feature agrees well with the non-existence of the expectation.
Another value of used in this work is introduced with relations , (7.10) .
(7.11)
For the reasons explained in Section 8.1 below, we term value of the critical value (cf., Line 10 of Table 2 ). Value derived below (see (7.22)) determines the corresponding, critical value of (see Line 10 of Table 2 ) as follows (see (2.8)) .
(7.12) Relation (7.13) stems from (7.11) and (7.12).
In view of (7.8) and (7.10), ODE (7.1) is equivalent to , .
(7.14)
Thus, dependence (7.7) allows one not only to combine homeostasis (see (3.4)) with hyperplasia (see (6.1)) resulting in the nonstationary-phase-transition (7.14) but also to provide a profound nonlinearity of the right-hand side of (7.14) in .
The behavior of where the cell apoptosis or cell mitosis is dominating is determined by the condition or respectively. In terms of ODE (7.14), these modes are described by the inequalities , the cell-death-dominating behavior, (7.15)
, the cell-proliferation-dominating behavior. (7.16) Both ODEs (3.4) and (6.1) can be derived from ODE (7.14). Indeed, in the limit case when and , (7.17) (7.14) becomes (3.4). The -aware generalization of (6.1) stemming from (7.14) is , , in the limit case when . (7.18)
In the opposite limit case, i.e. when , equation (7.14) leads to the following linear in asymptotic representation , , in the limit case when . (7.19) REMARK 7.2. One can easily check that the linear asymptotes on the right-hand sides of (7.18) and (7.19) intersect each other at or, in view of (7.10), at . This is a highly remarkable fact since the asymptotes explicitly depend on whereas the median picture for (see Remark 7.1) does not involve at all. (The asymptote value at the intersection point is .) The above mentioned fact emphasizes the inherently consistent nature of model (7.14). Moreover, the feature of to be the median of the probability distribution corresponding to (7.9) is represented in terms of ODE (7.14) with the fact that the value subdivides the -axis into two parts corresponding to the decreasing and increasing linear asymptotes. Subsequently, is, on a par with and , a characteristic value of inherent in ODE (7.14).
One can show that the right-hand side of ODE (7.14), as a function of , reaches the global ( The above facts enable one to derive an explicit expression for the critical scaled concentration . The derivation presented below is based on the analogous meanings of the minimum-point value (see (7.20)) and median value (see (7.10)).
It follows from the meaning of that this value corresponds to the global minimum in of the right-hand side of (7.14). If this right-hand side is schematically represented with the two linear asymptotes, as it is discussed in Remark 7.2, then the global-minimum value is the one for their intersection point, i.e. the median value . Remark 7.2 also explains why this value is an inherent characteristic of ODE (7.14). Subsequently, one arrives to the equality that, by virtue of (7.10) and (7.20), is equivalent to the following The expression for (see (7.10)) and (see (7.20)) corresponding to (7.23) and (7.22) is . When increases in the interval (7.24), i.e. from to , the critical concentration , as a function of (see (7.22)), strictly monotonically increases from to infinity. Also note that this function meets requirement (7.17). Subsequently, infinite corresponds to the ideal homeorhesis (see Section 3). Relation (7.24) is, according to the proposed model, the necessary and sufficient condition for a cell to be duplicating.
The cell-duplicability condition (7.24) poses bounds on the cell-cycle time . Indeed, as it follows from (3.8) and (6.2), (7.25) or, for the eukaryotic cells (6.3),
. Hence (7.24) is transformed into the relation .
(7.26)
Note that, in view of (7.22) In view of (7.23) and (3.8), ODE (7.14) is equivalent to equation
Compared to the form (7.14), the advantage of (7.29) is that, owing to (7.25) and (7.22), it is written in terms of the time quantities and which are among the model input parameters. We also stress that ODE (7.29) is the first description for a combination of homeorhesis and oncogenic hyperplasia which is the minimal model. The latter means that any simplification of the model leads to either quite particular cases (e.g., see Sections 3 and 8) or a destruction of the model. Thus, ODE (7.29) is the core description to be used in any subsequent modelling the mentioned combination. The above derivation is summarized as follows.
REMARK 7.3. The core phase-transition-endowed model of the maintenance of the cell number (see (1.1)) by the oncogenic-hyperplasia-extended homeorhesis describes the time dependence of the cellular-fluid concentration in (1.1) with the dedicated ODE, and includes the following relations:
• equality (2.8) which expresses the concentration in terms of the scaled concentration according to Remark 2.1; • nonlinear ODE (7.29) for the scaled concentration ; • relations (7.25), (7.22) for the time ratio and the critical concentration ; • initial condition (3.5), (3.6) for ODE (7.29); equality (3.6) expresses the initial function in (3.5) for the scaled concentration in terms of the initial function in (3.7) for the concentration .
The model input parameters are listed in Lines 1-7 of Table 1 . In Section 10 the model is used as the core for the diffusion-aware description of .
SUMMARY FOR THE CORE-MODEL ANALYTICAL ANALYSIS IN THE PARTICULAR CASE OF HOMEOSTASIS
Since the parameters , , and (as well as and because of (7.25) and (7.22)), depend on , ODE (7.29) can not be analyzed fully analytically in the general case. However, this analysis is possible in the particular case of homeostasis, namely, when homeorhesis is simplified to homeostasis by means of condition and, moreover, both and (and thus and ) are independent of . The analysis is summarized in this section.
We first note that, in the present case, there can exist the unique value of such that it is not an equilibrium point of equation (7.29) and is the ordinate of the inflexion points of the solution of the initial-value problem (7.29), (3.5). One can show that this value exists if and only if where is described with (7.20) and has features (7.21). Moreover, if the value exists, it is and the abscissa corresponding to ordinate is a function of . Additionally, the space position , is non-negative, i.e.
, and gives . One can point out the following three states:
• the generic state; the state when in (7.11) is fixed; • the ideal state; the limit state when tends to the upper bound of the interval in (7.11), i.e.
; this state is the best one for the host of the cells; • the brink state; the state when is equal to the lower bound of the interval in (7.11), i.e.
; this state is the worst one for the host of the cells.
Since (7.17) is valid (because of (7.22) and (7.23)) and (3.8) holds, the ideal state is presented with the model in Section 3. The only equilibrium point of ODE (3.4) is , and it is exponentially stable in the large, i.e. for all (see also the text on (7.15) and (7.16)).
Sections 8.1 and 8.2 consider the generic and brink states, respectively.
The generic state
At the generic state of the cellular fluid, the solution of the initial-value problem (7.29), (3.5) is defined for all and is described as an implicit function of in the following way (see also Dwight, 1961, integrals 160.01 and 160.11) , , if
The summary of the time behavior of is presented in Figure 1 . There are the following three mutually exclusive cases of the generic state (the drawings mentioned in the list below are those shown in Figure 1 ):
• the homeorhesis domain when (e.g., see (a)-(e)); it comprises (cf., Section 4) the regeneration subdomain (e.g., see (a)) and the inflammation subdomain (e.g., see (c)-(e)) separated from each other by the (stationary) homeorhesis point (see (b)); the regeneration subdomain corresponds to (7.16); the inflammation subdomain corresponds to (7.15); the latter subdomain includes the acute-inflammation region (e.g., see (c) and (ê) and the chronic-inflammation region (e.g., see (e)) separated from each other by value (7.20) (see (d)); • the (stationary) critical point ; • the oncogenic-hyperplasia domain when ; this domain corresponds to (7.16).
Value
, the upper bound of the chronic-inflammation region, is in the present work called critical because it separates the homeorhesis and oncogenic-hyperplasia domains from each other (see (f) in Figure 1) . Notably, the immediate proximity of these domains agrees with the fact that the development of cancer is usually attributed to inflammation. This idea was suggested as early as about AD 200 by the Greco-Roman physician Galen of Pergamum (AD 129 -c. 216).
We also note that in the homeorhesis domain, ODE (7.29) has the only equilibrium point and this point is exponentially stable. The homeorhesis-domain features are expected in a normal host of the cells.
The critical point (see (f) in Figure 1 ), is the case if and only if . If the latter identity holds, point is an unstable (see (1) and (2) in Figure 1 ) equilibrium point of ODE (7.29). Due to the instability, it would be difficult (if possible at all) to experimentally detect value . The oncogenic-hyperplasia domain is highly unfavorable to a host of the cells. Solution of initial-value problem (7.29), (3.5) is in this domain (see (g) in Figure  1 ), if and only if is in the domain. In this case, strictly monotonically increases from up to infinity, complying with (5.1) and being strictly convex. In other words, inequality activates the behavior that, in the limit case (5.1), results in the HT/NQ asymptote (6.1). This leads to the issues in the remark below. The threshold picture for the -stage (de)activation is similar to that of the threshold-activation approach of Beltrami and Jetsy (1995) and agrees with the wellknown vision discussed by Malumbers and Barbacid (2001, the box on p. 224).
According to our expression (7.22), the sub-reduction of can be achieved only by decreasing the time ratio (see (7.25)). The latter can in turn be implemented only by lowering the HT/NQ-cell-duplication time since lifetime in (7.25) is a quantity related to the ideal state (see the beginning of Section 8). The question is if there are any human-biology mechanisms that inhibit the stage by a simultaneous reduction of the duplication time .
The answer is affirmative: these mechanisms do exist. One of them is related to serum. For instance, Ohtsubo and Roberts (1993, the "Control" part of Figure  2 .(d)) report that is inversely proportional to the serum concentration in the invitro NQ-cell measurements. When this concentration tends to zero, increases unlimitedly but, what is more important, decreases when the concentration increases. Serum is known as a medium containing various mitogenic cytokines. Another group of the above mechanisms is inherently associated with the D-type cyclins (e.g., Kitazono, et al., 1999) . Overexpression of these cyclins (e.g., Sherr, 1995, p. 187; Kitazono, et al., 1999 , the section "D cyclins"; Hatzimanikatis et al., 1999, p. 635) shortens (in particular, by reduction of in (6.3)) and weakens the -stage effect thereby switching the cells to the (almost-)NQ behavior. The above two pathways are not necessarily independent. Indeed, "the D cyclins are unique in that they respond to external signals. This gives them a special role as cell division initiators." (Kitazono, et al., 1999 , the section "D cyclins"). "The fundamental role of D-type cyclins is to integrate extracellular signals" such as automitogens (AMGs), autocrine mitogenic cytokines, "with the cell cycle machinery." (Sherr, 1995, p. 187 ). Subsequently, the amplification effect of serum on the D-cyclin activities has already been confirmed (e.g., Sherr, 1995, p. 187) . This, in conjunction with the above facts, points out that the D cyclins can reduce the -stage effect and also endow the cells with the full NQ properties. Moreover, the "special role" of the D cyclins that they are directly influenced by intercellular signals opens up possibilities to discover AMG-or AMG-receptor-deactivating therapies or drugs for prevention or cure of oncogenic hyperplasias.
The brink state is a limit case of the generic state. This is discussed below.
The brink state
At the brink state, i.e. when , the only equilibrium point of ODE (7.29) is . It is semi-stable, more precisely, exponentially stable from below and unstable from above. Because of the instability, it can be difficult to experimentally detect it. Figure 2 shows the time-dependences of in the brink state. The state is called the brink one since the line (b) in Figure 2 can be regarded as the "brink" line in the following sense. A sudden deviation of up from this line attracts away from the line (see (2) in Figure 2 ) whereas an opposite deviation does not prevent the attraction of to the line (see (1) in Figure 1 ). This behavior can be recognized as an extremely particular example of bifurcation, the concept employed in an enormously wide range of mathematical problems (e.g., see Hazewinkel, Ed., 1988a, pp. 387-389 on bifurcation) . The brink state is the most dangerous for a host of the cells.
BIRTH, LIFE, AND DEATH OF ONCOGENIC HYPERPLASIA
In model (7.29) analyzed in Section 8, the value need not be independent of time . This dependence is accounted in what follows.
It stems from ODE (7.29) that
The time intervals where varies very slow and very fast compared to can alternate (e.g., see Figure 3 ). This behavior of is specified below. Assume that (see (a) in Figure 3 ), i.e. at the initial moment an inflammation is the case (cf., the inflammation subdomain in Figure 1 ). Subsequently, is in the homeorhesis domain. Assume as well that, in accordance with (7.27), due to a genotoxic reduction of and hence (see (7.27) and Remark 8.1), rapidly drops below (see (1) in Figure 3 ). In view of (9.1), the point of the intersection of and (see (b) in Figure 3 ) is the point of a local minimum of , and (since is, in its neighborhood, strictly convex) corresponds to the acute-inflammation region (cf., (c) or (ê) in Figure 1 ). Note that the intersection point corresponds the threshold values (8.2).
If the above low value of (and ) remains (almost) unchanged for a while, then, by virtue of (8.1), the cells do not enter the quiescent stage and, thus, oncogenic hyperplasia begins (see (c) in Figure 3 ). At the same time, it manifests the inflammation intensification from acute to chronic. Thus, the above intersection point is the birth of the hyperplasia and the beginning of the acute-to-chronic transition. Note that an inherent connection of oncogenic hyperplasia to chronic inflammation is well known from experiments (e.g., Kawai et al., 1994; Keenan et al., 1989 , and the references therein).
Let and, thus (see (7.25)), be pushed up sufficiently high to make (see (7.22)) higher than (see (2) in Figure 3 ). This can result from the immune surveillance (e.g., Franks and Teich, Eds., 1997, Sect. 16.3 .1; Life, Death and the Immune System, 1993), pharmaco-or radiotherapy-action, or other relevant factors (e.g., see Remark 8.1) . Subsequently (see (8.1)), the cells are no longer prevented from entering the stage. In this case, the point of the intersection of and (see (d) in Figure 3 ) is, due to (9.1), the point of a local maximum of (since is, in its neighborhood, strictly concave). It corresponds to the chronic-inflammation region (cf., (e) in Figure 1 ). This point is the death of oncogenic hyperplasia and the beginning of the inflammation relaxation from chronic to acute (see (e) in Figure 3). This scenario corresponds to sufficiently high (or ). If, on the contrary, the increased value of is not high enough and hence is boosted insufficiently (see the dotted line in Figure 3) , oncogenic hyperplasia will continue (see (ĉ) in Figure 3 ) resulting in a tumor. This allows for the well-known robustness of cancer (e.g., Kitano, 2003) .
If the above high value of (or ) and, thus, of remains (almost) unchanged for a long time, the tumor, i.e. the accumulated cell lump, of concentration is disintegrated, bringing to homeorhetic value . This happens since the stage is active at (see above). After that, due to the next genotoxic "attack" (i.e. reduction of ) can be reduced, oncogenic hyperplasia can begin again, and so forth. (These repeated processes are not shown in Figure 3 .)
The above picture shows how the core model allows for the genotoxic, -lowering activation of the hyperplasia resulting in its homeorhesis-dysfunction character. REMARK 9.1. Every intensification of inflammation from acute to chronic is, in the dynamical terms, oncogenic hyperplasia. Each time when the latter ends, the accompanying chronic inflammation achieves a local maximum in time. If chronic inflammation does not achieve this maximum, oncogenic hyperplasia does not end.
The core model in Remark 7.3 is, similar to any other model, nothing but a hypothesis that has to be verified experimentally. The verification should, first of all, include a detailed description and operation guidance for the corresponding measurement equipment that would enable one to validate the model precisely in the very same sharp, unambiguous, and time-space dependent terms which the model is formulated in. The model is ready for verification since it does not contradict any qualitative aspect of homeorhesis, oncogenic hyperplasia, or the cell cycle.
THE DIFFUSION GENERALIZATION OF THE CORE MODEL TO MORPHOGENY: THE PHASTRAM MODEL
Morphogeny, a process of formation of a tissue, organ, tumor, or other similar body is not only inhomogeneous in space but also includes diffusion of species. The simplest way to correspondingly extend the core model (see Remark 7.3) is involvement of the reaction-diffusion approach applying it to the simplest domain, i.e. the entire physical space (see the text above (1.1)). The reaction-diffusion treatment of morphogenesis and self-organization in biology was pioneered by Rashevsky (1940a Rashevsky ( , 1940b Rashevsky ( , 1940c ) (see also Turing, 1952 Turing, , 1992 , as well as Levin and Segel, 1985 , for a survey).
According to the above recipe, one takes into account the corresponding diffusion term (cf., Burton, 1966; De Angelis and Preziosi, 2000; Pettet et al., 2001; Akabani et al., 2002; Ferreira et al., 2002; Kar et al., 2002; Jiang et al., 2002) . This extends ODE (7.29) to the following reaction-diffusion equation (RDE) , , , (10.1) where is the diffusion parameter of the cellular fluid (e.g., see (10.4) below) and column is the Hamilton differential expression in the entries of vector , i.e.
. The familiar initial condition (3.5) is also the one for RDE (10.1).
Cells are enormously big and heavy compared to elementary particles (cf., Mamontov and Willander, 2003a) . Subsequently, the shifted (and hence, generally nonequilibrium) Maxwell-Boltzmann (shifted-MB) statistics may be valid for cells even at high values of (Mamontov and Willander, 2003a) . Indeed, in the shifted-MB case, is coupled with the cellular-fluid chemical potential with the well-known relation (e.g., Mamontov and Willander, 2003a, Sect. 3) where (e.g., Mamontov and Willander, 2003a , (9) is the characteristic scaled concentration of the cellular fluid (see Line 13 of Table 2 ), is the quantum-spin number of a cell (see Line 8 of Table 1 ), is the Planck constant ( ), is the Boltzmann constant ( ), is the absolute temperature of the cellular-fluid host (see Line 9 of Table 1) , is the mass of a cell (cf., Line 10 of Table 1 ). The validity criterion for the shifted-MB statistics is the inequality (e.g., Mamontov and Willander, 2003a, (12) .4) in (10.1) is also -independent. It is shown (Mamontov and Willander, 2002 , (20) If the cell-involving reactions (cf., the last term on the right-hand side of (10.1)) are present, then the mutual non-interaction is, strictly speaking, not the case. Subsequently, the above statistics (and the corresponding, concentration-independent diffusion parameter ) is at best an approximation.
Since the -domain in (10.6) (or (10.1)) is the entire space, the solution of (10.6) is sought as the solution of the corresponding Cauchy problem (10.6), (3.5).
REMARK 10.2. The reaction-diffusion version of the core model (see Remark 7.3) is the model for the phase-transition-endowed maintenance (PhasTraM) of the cell number (see (1.1)) by the oncogenic-hyperplasia-extended homeostasis. The PhasTraM model describes the time-space dependence of the cellular-fluid concentration in (1.1) with the dedicated nonstationary RDE whereas the above core model describes with the related ODE. The PhasTraM model includes the relations below:
• equality (2.8); it expresses the concentration in terms of the scaled concentration according to Remark 2.1; note that, if necessary, the following can be applied; volume of a tumor is determined in terms of , namely, where is the tumor locus (empty if there is no tumor) and is described with (7.12); if , i.e. a tumor is formed, its shape and size are pointed out by boundary ; • nonlinear RDE (10.6) for the scaled concentration ;
• relations (7.25) and (7.22) for the time ratio and critical concentration ; • initial condition (3.5), (3.6) for RDE (10.6); equality (3.6) expresses the initialvalue function of the scaled concentration (see (3.5)) in terms of the initial-value function in (3.7) for concentration .
In the entire physical space , the PhasTraM model describes with the Cauchy problem (10.6), (3.5).
The above term "phase-transition" is due to the fact that the PhasTraM model is inherently associated with Schlögl's theory of non-equilibrium phase transitions of both the first and second orders. This is explained in Appendix B in more detail. The fluid-solid Schlögl-type phase-transition nature of the PhasTraM model is one of the next steps in development of the biomedicine-related bistable approaches exemplified with the well-known Hodgkin-Huxley (HH) model (e.g., Hazewinkel, 1988a, p. 292) . It was proposed in 1952 to describe the electrical activity of nerve cells rather than formation of a tumor. In contrast to single nonlinear RDE (10.6) in the PhasTraM model, the HH model includes at least four nonlinear equations where one equation is also a nonlinear RDE. This points out a substantially higher complexity of the HH approach. At any rate, an interpretation of the HH model in terms of a genotoxically-activated tumor formation would facilitate its application to oncogeny.
The overall spatial inhomogeneity of the PhasTraM model is explicit when the Cauchy problem (10.6), (3.5) in the PhasTraM model (see Remark 10.2) can be solved analytically. The latter can be done for the ideal state and the -idependent . In this case, the nonlinear RDE (10.6) at every fixed , presents the diffusion Gaussian "bell" in centered at . This "bell" affecting the first term in the brackets in (10.8) determines the spatial inhomogeneity and, thus, the morphogenic aspects of the cellular-fluid time-evolution at the ideal state (see the list below (2.42)). In other words, expression (10.8) extends the ideal-state model (3.4), (3.5) to the general, spatially inhomogeneous case.
Obviously, the corresponding extensions of the core description (7.29), (3.5), (3.6) by the PhasTraM model are also available even if the model cannot be solved analytically, for example, at more complex states such as those in Sections 8.1 and 8.2. Indeed, the nonlinear RDE (10.6) differs from the linear RDE (10.7) in that the coefficient in front of depends on . However, if one replaces in this coefficient with the initial value thereby linearizing (10.6) (that results in (C.1)), then the corresponding solution (i.e. the one of the Cauchy problem (C.1), (3.5)) is (e.g., Freidlin and Wentzell, 1998, p. 38) , , . (10.9) It approximately describes including the development of the above diffusion Gaussian "bell" when the cellular fluid is not in the ideal state (cf., (10.8)). Loosely speaking, those fragments of surface which are stimulated by the switching of to sufficiently low values (see Figure 3 ) form (islands of) a tumor whereas the rest of surface (i.e. its parts for which the low values of are still sufficiently high) relax to homeorhetic concentration . Expression (10.9) arises in the considerations leading to the analytical-numerical time-slice method for numerical solving the Cauchy problem (10.6), (3.5). This method is proposed in Appendix C which also notes that the accuracy of formula (10.9) is not very high. Subsequently, (10.9) can serve only as a semi-qualitative estimation. A more accurate picture can be obtained by the time-slice technique.
DISCUSSION, CONCLUDING REMARKS AND DIRECTIONS FOR FUTURE RESEARCH
Modern biomedicine is mainly devoted to an enormous number of observations and measurements on living matter. In spite of that the settings of these observations and measurements are highly specialized and quite particular, the corresponding data provide an important insight into various fragments of life processes. However, the fragmentary paradigm inherent in the biomedical facts cannot resolve the gradual time-space dynamics of homeorhesis and oncogenic hyperplasia. A possible way to repair this mismatch is Rashevsky's "unity in diversity" (see Section 1). It can be approached, for example, by the related mathematical-physics models.
There is a considerable progress achieved in this direction. For instance, some results on the topic are presented by Lopez (et al., 1999) in terms of the tumor growth resisted by drugs. One of the key issues according to (Lopez et al., 1999, p. 13028) is: "The assumptions and definitions underlying the model-based approach are potentially testable, and this may allow for clearer quantification and interpretation of the complex concepts of synergism... for in vivo tumor models". Related results were reported by other authors such as Sherratt (1993) , Stöcker and Curci (1998) , Bellomo and De Angelis (1998) , Tan and Chen (1998) , Bellomo (et al., 1999) , Bellomo and Preziosi (2000) , Chaplain (et al., 2001 ), Ferreira (et al., 2002 , Bellomo (et al., 2003) . The review paper of Vicini (et al., 2002) provides a deep insight into the crucial role of mathematical modelling in various fields of biomedicine.
The above development can be regarded as a response to the following note on cancer (Hughes, 2001) : "For such a complex disease, it is essential that we tackle it with diverse thinking and practice." The present work is a step toward the "unity in diversity" and is in line with systems biology (e.g., Pennisi, 2003; Kitano, 2002) . The main outcome is the PhasTraM model described in Remark 10.2. Certain aspects of cell biology are elucidated by other results such as Hypothesis 7.1 (stemming from the discussion on (7.28)) and Remark 9.1.
The PhasTraM model is the first minimal model (see the text below (7.29)) that combines homeorhesis with oncogenic hyperplasia where the latter is regarded as a genotoxically activated homeorhetic dysfunction. This dysfunction presents transitions of the cellular fluid from a fluid, homeorhetic state to a solid, hyperplastic-tumor state, and back. The key part of the model is RDE (10.6) where the biochemical-reaction rate enables the above transition generalizing the well-known Schlögl physical theory of the non-equilibrium phase transitions (cf., Table 4 ). The feature of the PhasTraM model to be the minimal model presumes further extensions, for instance, to the generalized-kinetics theory developed by Bellomo (et al., 2003a Bellomo (et al., , 2003b ) (see also Willander et al., 2004) . The above genotoxic activation is treated by means of the critical concentration (see (7.12) and (7.22)) and the nonquiescentcell-duplication time (see in Remark 6.1, (7.25), and Remark 8.1). The model can describe both formation and disintegration of a tumor, and even a sequence of the formation/disintegration events.
The PhasTraM model includes a limited number of carefully selected input parameters listed in Table 1 . Each of them has a specific biological, biophysical, or physical meaning. A determination of the key input parameters is considered by who also generalizes the model to the action of the anti-AMG or anti-AMG-receptor drugs (see Remark 8.1 on AMGs). Preliminary results on this action were reported by . When the input parameters are properly determined, the model predictive capabilities can be used in development of the quantitative measures for prevention of oncogenic hyperplasia in cancer and other proliferative diseases (e.g., listed in Section 1).
The key output characteristic of the PhasTraM model is the cellular-fluid concentration as a time-space-inhomogeneous function, . It is continuously differentiable and, thus, describes the transitions of the fluid from the homeorhesis state to the solid, tumor state in a smooth way. There are no sharp boundaries, i.e. the ideal jumps (of zero length in space) of the cell concentration, between the domains of the homeorhesis-and tumor-cell populations. This agrees with what is known in biomedicine. The concentrations changes from the normal to tumor values without discontinuities. Moreover, the above ideal concentration jumps are unphysical. If, however, there is a need to estimate the geometric features of a tumor (if it is formed) in specific quantities, the PhasTraM model provides (see Remark 10.2) the time-dependent tumor locus , boundary , volume , as well as the tumor shape and size in terms of . In the literature, there are many other models which describe oncogeny by means of RDEs. The main distinguishing features of the PhasTraM model are the following.
• In contrast to, for instance, Pettet (et al., 2001 ) and Ferreira (et al., 2002) , the PhasTraM model does not idealize the homeostasis-cell/tumor-cell system to a system of exactly two strongly different phases with a sharp boundary separating a solid tumor from the surrounding normal cells. • The PhasTraM model does not assume the shape of a tumor to be of any specific (e.g., spherical) form, and does not tie down a growth of the tumor to an enlargement of the spatially homogeneous single-phase, solid spheroid (cf., Marušić et al., 1994a Marušić et al., , 1994b Ward and King, 1997; Pettet et al., 2001; Ward and King, 2003) ; notably, these assumptions are not used by Ferreira (et al., 2002) where the model can generate a variety of the tumor shapes. • The PhasTraM model does not artificially subdivide the cells into the ones that are normal and tumoral (cf., Sherratt, 1993) or living and dead (cf., Ward and King, 1997) . • The PhasTraM model in the case when all the input parameters (see Table 1) are available includes only one RDE, (10.6) in contrast to, for instance, Ward and King (1997); Jiang (et al., 2002), and Ferreira (et al., 2002 ).
• The input parameters of the PhasTraM model are both time-and space-dependent but not limited to any particular forms of these dependences in contrast to, for instance, Akabani (et al., 2002) or Kar (et al., 2002 ).
• The PhasTraM provides the explicit connection (e.g., see above) of the cell-population behavior to an intracellular phenomena, namely, the activation/deactivation of the -stage of the cell cycle. All the referred works, except Pettet (et al., 2001) , do not include a cell-cycle-based genotoxic activation of oncogeny. None of them stresses the homeorhesis mode, thereby leaving the homeorheticdysfunction facet of oncogeny (e.g., Trosko et al., 1990) beyond the analysis.
• The PhasTraM model describes hyperplasia, the first stage of oncogeny (and the core of many other proliferative diseases (see Section 1). This offers the possibility of consistent modelling of other stages of oncogeny (cf., Remark 2.2).
We suggest four directions for future work on the PhasTraM model.
• Experimental testing the model. The testing should be done in terms of the key output parameter, i.e. the above mentioned cell concentration . The corresponding measurement technique must provide the gradual time-space dependence either in-vivo or in those in-vitro settings which were certified for a complete compliance with the related in-vivo environment (e.g., certified three-dimensional (3D) in-vitro experiments). A discussion of the 3D in-vitro methods can be found in Abbot (2003) . An example of the methods able to measure the cell concentration is the ultrasound backscattering which has already been tested for cells (e.g., Sennaoui et al., 1997) , the cell-size particles (e.g., Panetta et al., 2003) , and the molecule-size particles (e.g., Baucke et al., 2004) .
• Interpretation of the model in terms of the cell-AMG interactions (see Remark 8.1 on AMG), determination of the key input parameters including the measurement-technique issues, and incorporation of a description for the action of the AMG-or AMGR-deactivating drugs into the model. The first step in this direction is the results of further extended by Mamontov (et al., 2005) . The main purpose of the above drugs is to increase the HT/NQ-cell duplication time (see (6.3)) thereby boosting (see (7.22) and Remark 8.1) by means of (see (7.25)).
• Analysis of the cumulative effect of the AMG-based drugs and radiotherapy on formation and disintegration of a tumor. As it is shown by , if the concentration rate due to the radiotherapy-caused cell death is where , then the PhasTraM RDE (10.6) is generalized to , , . (11.1)
It points out that radiotherapy increases the threshold for (see Remark 8.1) in times compared to . This in particular improves the aforementioned drug action. Equation (11.1) is the very one that can underlie the cumulative-effect analysis.
• Incorporation of a description for explaining the nonquiescent-cell-duplication time (e.g., see above) into the PhasTraM model. There are the recent works that can serve as a good starting point (e.g., Hatzimanikatis et al, 1999; Steuer, 2004; Novák and Tyson, 2004 ).
• Extension of the above cell-AMG system to the case when the cells and AMGs are described with a nonlinear RDE and a generalized kinetic equation, respectively. The generalized-kinetics theory (e.g., Bellomo et al., 2003a) can better allow for the cytokine-relevant scales of the AMG-related phenomena and is more flexible to endow the models with features of "physical biology" Yates (1979) .
All the above developments can open a way to such innovative practical tools as early-diagnostics techniques, therapies or drugs for prevention of oncogenic hyperplasia or disintegration of tumors.
APPENDIX A. THE FUNDAMENTAL ROLE OF A POINT HYPERPLASTIC TUMOR IN ONCOGENY AND ITS DEFINITION IN PHYSICAL TERMS
Different sciences can define the same object in different ways. Here is an example of a tumor definition common in medicine. DEFINITION A.1. (Franks and Teich, Eds., 1997 , the first paragraph of Sect. 1.5) "It is not possible to define a tumor cell in absolute way. Tumors are usually recognized by the fact that the cells have shown abnormal growth, so that a reasonably acceptable definition is that tumor cells differ from normal cells in that they are no longer responsive to normal growth-controlling mechanisms. Since there are almost certainly many different factors involved, the altered cells may still respond to some but not to others. A further complication is that some tumor cells, especially soon after the cells have been transformed from the normal, may not be growing at all. In the present state of knowledge any definition must be 'operational'."
A few factors in this description attract attention. Firstly, a tumor cannot be defined in unambiguous way by just listing its features. Secondly, in contrast to normal cells, tumor cells do not respond to normal growth-controlling mechanisms and, as a result, grow abnormally. Thirdly, this nonresponsiveness is not a distinguishing feature since some tumor cells may respond to the above mechanism whereas some nontumor cells may be nonresponsive. Fourthly, the abnormal growth is not a distinguishing feature either since some tumor cells may not be growing at all, at least for a rather long time. Fifthly, the definition of a tumor must be "operational" where the meaning of the latter term is not disclosed thereby leaving a freedom to multiple and, in fact, arbitrary meanings. The five listed singular features of Definition A.1 open a way to the alternative definitions (hopefully "operational"). We suggest one of them below. It is related to the simplest, point hyperplastic tumors.
A.1. Point hyperplastic tumor as the fundamental stage of oncogeny
A point hyperplastic tumor is the first and hence inevitable stage of oncogeny. REMARK A.1. A hyperplastic tumor is usually a very small, point-like "clump" (cf., Franks and Teich, Eds., 1997, the right column on p. 24) or "lump" (cf., Franks and Teich, Eds. 1997 , the left column on p. 330) which are the "dense packing" (e.g., Franks and Teich, Eds., 1997, the right column on p. 361) of tumor cells or the structures where tumor cells are "closely packed" (e.g., Franks and Teich, Eds., 1997, the right column on p. 10). Note, however, that a pathological hyperplastic lesion can sometimes be on the order of centimeters in size.
All (solid) tumors grow from respective hyperplastic "seeds". In this respect, a hyperplastic tumor is the simplest but fundamental stage of oncogeny.
Hyperplasia presents an increase in the number of cells within a given zone in the course of time. In general, hyperplasia arises to meet special needs of the body and subside once these needs are met. Hyperplasias are the result of the sustained impact over time of stimulatory influences together with a loss of growth-inhibitory factors that are normally found within or around cells. As long as the loss of inhibition of cell growth is temporary, the capacity for enhanced cell proliferation when necessary has obvious advantages (cf., the regeneration subdomain in Section 8.1). However, if normal cells perform mutational transformations, they can permanently lose their ability to respond to growth-inhibitory factors. The corresponding hyperplasia becomes oncogenic, capable of resulting in a hyperplastic tumor.
A.2. The definition of a point hyperplastic tumor in terms of the volume-scaling method Within a given zone, i.e. a bounded space domain, say, of volume which is finite due to boundedness of , an increase of the cell number, say, is equivalent to an increase in the average cell-number volumetric density, or the average cell concentration, .
( Since a typical volume of a cell is on the order of tens of cubic micrometers, domain is microscopic at the very beginning of hyperplasia when it starts to grow from one cell or a few cells. Subsequently, definition (A.2) must be extended to microscopic domain as well, including the case when it comprises a single cell and, for completeness, even a single volumeless particle, i.e. a space point. Indeed, multicomponent fluids are associated with different species (e.g., see the -component relation (A.4) below), in particular, quite small molecules and, in some cases, also the electrons which are of zero volumes. Luckily, the concentration can be defined rigorously not only as the above nonlocal, integral term but also as a local quantity, the concentration , i.e. the one associated with arbitrary point in . Owing to that, one can define the point hyperplasia in the following way hyperplasia at point in is an increase in with time. 3) are valid for any hyperplasia, normal or oncogenic. Coming back to a hyperplastic tumor, we note its features in Remark A.1. They mean that the corresponding tumor cells present a community where each cell does not have a room sufficient for normal motion because the volume is (to a considerable extent) occupied by the very bodies of the cells and perhaps other obstacles different from these bodies. Loosely speaking, normal motion of the cells is blocked. Still the cell volume or concentration as well as the influence of the obstacles may vary in time. Physically, a hyperplastic tumor is, in a sharp contrast to normal hyperplasia, a cluster (ordered or disordered) of cells (cf., the entry "Presentation" in the article " Cancer", Encyclopaedia Britannica Online, 2003) . Let us consider this clustering in specific terms, for instance, those typical in common statistical mechanics.
To do that, we consider the -component fluid ( ) of particles (such as cells or molecules) and denote the concentration of the th component at timespace point with , . Let be the volume of the particle in the th fluid component. Let also be the ratio of the fraction of the volume occupied by the bodies of the fluid particles to the fraction of the volume unavailable for the particle motion at point . Then, according to the volume scaling method, or VSM (see the text above (2.1)), quantity (A.4) is the fraction of the space volume which is available for motion of the fluid particles at point . Quantity is due to the aforementioned obstacles. More precisely, it can be a manifestation of various physical or geometrical effects. For instance, it can result from the repulsive interparticle forces. Another example concerning purely geometrical issues (Mamontov and Willander, 2001, p. 217) shows that, if , then for the hard spheres occupying the entire physical space. Unlike this, one can apply the approximate value (A.5) to a fluid formed by highly elastic and freely moving particles (such as red blood cells in blood). In case of a cellular fluid in mammalian tissues, the extracellular matrix contributes to . In case of the tumor cells at the angiogenesis stage of oncogeny, is affected by the volume fraction occupied by the blood vessels in the tumor (cf., the data in Table 1 of Akabani et al., 2002) .
Fraction ( Note, however, that not every system loosely understood in biomedicine as a cluster of cells is a tumor. For instance, mesenchymal tissue is made up of clusters of cells (grouped together but not closely adhered to one another). These normal, nontumor clusters usually do not have the "utmost-concentration" property (A.6) (see also (A.4)). Thus, condition (A.6) is the distinguishing feature of a tumor.
We also stress that expression (A.4) explicitly shows that the fraction depends on all the tissue components at point . This, in conjunction with (A.6), agrees with the well-known idea (e.g., Franks and Teich, Eds., 1997 , the right column on p. 8): "The developed tumor usually consists of a mixed population of cells, which may differ in structure, function, growth potential, resistance to drugs or X-rays, and ability to invade and metastize.". REMARK A.3. A dynamic model developed consistently need not involve the assumption that the particle volumes are zero, i.e. , , or, equivalently, . However, even if a dynamic model is developed under this assumption, then it can, in the first approximation, be generalized to the nonzero-volume case as follows. According to the VSM, one replaces the concentrations in the model with the scaled concentrations and complements the model with the corresponding equations, i.e. , .
(A.7)
Importantly, equations (A.4) and (A.7) establish a one-to-one correspondence between and .
The recipe in Remark A.3 radically improves the adequacy of even very simple models. We illustrate that in Section 11 and Appendix B.
APPENDIX B. RELATION OF THE CORE AND MINIMAL MODELS TO SHLÖGL'S THEORY OF NON-EQUILIBRIUM PHASE TRANSITIONS OF THE FIRST AND SECOND ORDERS
The treatment in Section 8 enables one to completely analyze the -dependence of the concentration , an output characteristic of the core model (see Remark 7.3). This is summarized in Table 3 Importantly, the time dependence of in Table 3 at is qualitatively the same as that stressed by Schlögl (1971, in Fig. 3 where , , and correspond to , , and , respectively). Moreover, the proposed phase-transition-aware core model (see Remark 7.3) is of the Schlögl type.
Indeed, substituting (2.7), (3.3) and (7.12) into (7.29), one obtains the following ODE for , ,
where (cf., Line 12 of Table 2) .
(B.4)
The corresponding initial condition is (3.7). At the generic state, function (B.4) has two (exponentially) stable roots (see Lines 1 and 5 of Table 3 ) separated by one unstable root (see Line 3 of Table 3 ). This is qualitatively the very same picture as that described by Schlögl (1972 , the text between (10.2) and (10.3)) in connection with a first-order non-equilibrium (and, thus, nonstationary) phase transition (NEPT) (see also (9.35) and Sect. 9.3 of Haken, 1977, or (11.47) and Sect. 12.C of Reichl, 1998) . Subsequently, according to Schlögl's theory (1972, Sect. 3), dependence (B.4) in the generic state corresponds to the above transition that is noted in Line 1 of Table 4 . Function at the ideal or brink state is a particular case of (B.4). Indeed, expression (B.4) in the case of (B.1) becomes , at the ideal state. (B.5) This function has one (exponentially) stable root (see Line 1 of Table 3 ) and one unstable root (see Line 5 of Table 3 ) that corresponds to Schlögl's picture of a second-order NEPT (see Schlögl, 1972, Sect. 2; Haken, 1977 , the text on (9.8), (9.9) and (9.14); Gardiner, 1994, Sect. 8.3.3) . This is noted in Line 2 of Table 4 .
In the case of (B. This function has one (exponentially) stable root (see Line 5 of Table 3 ) and one unstable root (see Line 1 of Table 3 ) that, similarly to the ideal state (see above), qualitatively corresponds to the aforementioned Schlögl picture of a second-order NEPT. This is highlighted in Line 3 of Table 4 . Note that the roots which are stable and unstable in case of (B.6) are, on the contrary, unstable and stable, respectively, in case of (B.5). Thus, the initial-value problem (B.3), (B.4), (3.7) which is equivalent to the core model (see Remark 7.3) includes both first-and second-order-NEPT readings developed by Schlögl. This is summarized in Table 4 .
Remarkably, all the above advantages are achieved owing solely to Definition A.2 (rather than Definition A.1) and VSM, in particular, Remark A.3. REMARK B.2. Physically, hyperplasia can be regarded as a first-or second-order NEPT. Each of them is described with Schlögl's theory. The fact that the Schlögl-type core model (see Remark 7.3) originates from the interpolation (7.1), (7.2) (resulting from its particular cases (3.4) and (6.1)) confirms that this interpolation is highly relevant and viable.
Another advantage of the present model is emphasized in the following remark. REMARK B.3. Schlögl (1972) applies a quadratic and cubic dependences for function in his theories of NEPTs of a first and second orders respectively. Our function (B.4) not only allows for both the Schlögl theories but also is less schematic than the above quadratic and cubic dependences. For instance, Schlögl's cubic dependence is noted as a considerable problem (e.g., Haken, 1977 , the discussion on p. 291 on the dependence (9.136)). In contrast to this, function (B.4) follows from the interpolation stressed in Remark B.2.
The corresponding diffusion-aware generalization is associated with RDE (10.6). Indeed, this equation under condition (2.7) is a RDE of the Schlögl type (Schlögl, 1972, Sect. 3) (see also Haken, 1977, Sect. 9.3) . Indeed, substitution of (2.7) into (10.6) and allowing for (2.2) and (7.12) gives RDE Table 4 , RDE (B.7) (equivalent to (10.6)), includes both first-and second-order-NEPTs developed by Schlögl. If, in any of the cases (B.4)-(B.6), one neglects the second term on the right-hand side of RDE (B.7), then RDE (B.7) is the well-known Schlögl RDE (see Schlögl, 1972 , (4.1) or Haken, 1977 ) for a first-order NEPT; Gardiner, 1994, (8.3 .63) for a secondorder NEPT) modified with (7.12). The neglected term results from allowing for the nonzero volume of a cell by means of (2.4) and (2.5). The Schlögl RDE for a first-or second-order NEPT is well known in physics and chemistry as one of the key models. The literature on this topic includes hundreds of works. To mention a few, we point out Albano (et al., 1984) and Reichl (1998, Sect. 12.C) . It is, however, much less known in biomedicine. The present work is the first one where the Schlögl-type model is proposed for the hyperplasiaextended homeostasis and, moreover, homeorhesis.
APPENDIX C. THE TIME-SLICE METHOD FOR SOLVING THE CAUCHY PROBLEM FOR THE PHASTRAM RDE
Problem (10.6), (3.5) is the Cauchy one and therefore is formulated in the entire space . The latter feature noticeably complicates a numerical solving. The corresponding purely numerical techniques (such as the finite-difference or finite-element methods) are quite time-consuming. The multiple analysis, the core of computer-assisted research and design, requires much longer computing time. Along with this, it is desirable to implement this analysis on common computers, those of modest computing capabilities, such as notebooks. There are many users interested in a mobile and affordable computing: students, teachers, biomedical researchers, and engineers at the pharmaceutical industry, among others.
The above issues draw attention to analytical-numerical approaches (e.g., Mamontov and Willander, 2001, Ch. 8) rather than the purely numerical ones. An example is considered in the present appendix that proposes the analytical-numerical method to solve the Cauchy problem (10.6), (3.5).
As it is noted in the text above (10.9), if one replaces in the coefficient in front of in RDE (10.6) with initial value , the resulting version of (10.6) is , , , (C.1)
where, according to , parameters , (see (7.25)), and (see (7.22)) generally depend on , i.e. ,
, .
ed to the research environment enabling the authors to develop the results of the present work. Helen Bridle, Department of Chemistry and Biosciences, Chalmers University of Technology Corp. (Gothenburg, Sweden), is warmly acknowledged for reading the manuscript and useful remarks which helped the authors to improve the text. The authors are much obliged to Professor R. Hultborn, Department of Oncology, Sahlgrenska University Hospital (Gothenburg, Sweden) for the fruitful discussion and comments which stimulated the authors to emphasize a series of the key advantages of the proposed treatment. 1 of this table) 6 (3.6); initial value of , i.e. its value at the initial time point (cf., (3.5)); is a function, 7 (3.8) 8 (6.2) 9 (7.10); the median value of ; the median of the distribution corresponding to density (7.9) 10 (7.12); critical value of (7.13) 11 (7.22); the critical value of ; it is the semi-stable equilibrium point of ODE (7.29); specifically, it is asymptotically stable from below and unstable from above; this feature (in the case of a sudden deviation of from line at the point denoted with the sign "×") is outlined with options (1) and (2); (c) -the oncogenichyperplasia domain, .
Figure 3. Qualitative -dependence of solutions of equation (7.29) and critical scaled concentration at the generic state according to the scenario described in Section 9. The values of are coupled with those of with equality (7.22). The sign " " denotes the initial value of . The generic state is exemplified and specified with the following curves and points: (a) -the inflammation subdomain of the homeorhesis domain at the generic state (similar to (c)-(e) in Figure 1 ) where inflammation relaxes from chronic to acute; (b) -the point of the intersection of the decreasing and ; it is the point of a local minimum of and corresponds to acute inflammation (since is strictly convex); the point indicates both the birth of hyperplasia and the beginning of the inflammation intensification from acute to chronic; (c) -the oncogenic-hyperplasia domain (similar to (g) in Figure 1 ) where inflammation intensifies from acute to chronic; (ĉ) -the version of the behavior (c) of corresponding to the dotted-line version of the behavior of ; (d) -the point of the intersection of the increasing and ; it is the point of a local maximum of and (since is strictly concave) corresponds to chronic inflammation; the point indicates both the death of hyperplasia and the peak of chronic inflammation, i.e. the beginning of the inflammation relaxation from chronic to acute; (e) -the inflammation behavior similar to that in the above case (a); (1) -a fast decrease in due to the genotoxic events decreasing via decrease in (see (7.25)); (2) -a fast and high (or medium -the dotted line) increase in due to the immune surveillance, pharmacotherapeutic actions, radiotherapy, or other relevant factors that increase by increasing . Remark 9.1 stresses certain features of the above behavior.
